John Rondoni - 31 May 2022 Form 3 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Technology Officer
Signature
/s/ Bryan Phillips, Attorney-in-Fact for John Rondoni
Issuer symbol
INSP
Transactions as of
31 May 2022
Net transactions value
$0
Form type
3
Filing time
08 Jun 2022, 19:41:29 UTC
Next filing
04 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INSP Common Stock 10,610 31 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 12,387 $2.07 Direct F1
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 6,218 $0.9400 Direct F1
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 12,098 $42.15 Direct F2
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 12,250 $71.00 Direct F3
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 8,600 $194.82 Direct F4
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 11,181 $194.30 Direct F5
holding INSP Employee Stock Option (Right to Buy) 31 May 2022 Common Stock 3,173 $227.53 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is fully vested and exercisable.
F2 The option has vested or will vest and become exercisable as to 25% of the underlying shares on the first anniversary of December 18, 2018 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
F3 The option has vested or will vest and become exercisable as to 25% of the underlying shares on the first anniversary of December 16, 2019 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
F4 The option has vested or will vest and become exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
F5 The option has vested or will vest and become exercisable as to 25% of the underlying shares on the first anniversary of May 28, 2021 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
F6 The option vests and becomes exercisable as to 25% of the underlying shares on the first anniversary of February 1, 2022 and the remaining 75% of the underlying shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Remarks:

Exhibit 24 - Power of Attorney